A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
2021 · Nature Communications · 117 citations
https://doi.org/10.1038/s41467-021-26499-y
W
Weina Sun
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
2.2K
Citations
27
h-index
40
i10-index
Weina Sun is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies & Respiratory viral infections research. The author has an h-index of 27, co-authored 73 publications.
ORCID: 0000-0002-2435-5047Papers by this author
worksSafety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
2022 · EClinicalMedicine · 54 citations
https://doi.org/10.1016/j.eclinm.2022.101323
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
2024 · Cell Reports · 30 citations
https://doi.org/10.1016/j.celrep.2024.114922
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models
2025 · Frontiers in Immunology · 8 citations
https://doi.org/10.3389/fimmu.2025.1524477
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
2024 · Vaccine · 4 citations
https://doi.org/10.1016/j.vaccine.2024.126586
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
2025 · Proceedings of the National Academy of Sciences · 2 citations
https://doi.org/10.1073/pnas.2416628122
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat